绿康生化 (002868.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−134.5x

Market Cap

CNY 3.35B

MomentumView details →

1D Return

−2.35%

YTD Return

−23.38%

RSI (14)

66.6

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−134.5x

Market Cap

CNY 3.35B

RSI (14)

66.6

MomentumView details →

1D Return

−2.35%

YTD Return

−23.38%

ProfitabilityView details →

Gross Margin

11.15%

Net Margin

−20.63%

EBITDA Margin

−6.10%

ROE (TTM)

−149.24%

ROA (TTM)

−13.41%

Asset Turnover

0.66x

GrowthView details →

Revenue YoY

−20.28%

EPS YoY

+76.50%

FCF YoY

—

Revenue CAGR 3Y

+16.13%

EPS CAGR 3Y

+68.53%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

2.97x

Current Ratio

0.58x

Quick Ratio

0.39x

Div Yield

—

Div Rate

—

Div Growth 1Y

+7.06%

Financials snapshotView financials →

Revenue (TTM)

502.95M

Net Income (TTM)

−103.75M

Op. CF (TTM)

−37.00M

Latest newsMore news →

Lvkang Biochemical announced on August 18, 2026 that its board approved the sale of a 90.0003% stake in subsidiary Fujian Lv'an Biological Pesticide Co., Ltd. to Shanxi Xinyuan Huakang Biotechnology Co., Ltd. for 31.5811 million yuan.17d ago

Lvkang Biochemical announced its financial results for the first half of 2026, reporting a net profit of 7.316 million yuan, turning around from a loss of 58.5709 million yuan in the same period last year.37d ago

Similar companies

维科精密301499.SZ 万马科技300698.SZ 丰茂股份301459.SZ 乔治白002687.SZ 秀强股份300160.SZ 三和管桩003037.SZ Find similar companies →

Latest newsMore news →

Lvkang Biochemical announced on August 18, 2026 that its board approved the sale of a 90.0003% stake in subsidiary Fujian Lv'an Biological Pesticide Co., Ltd. to Shanxi Xinyuan Huakang Biotechnology Co., Ltd. for 31.5811 million yuan.17d ago Lvkang Biochemical announced its financial results for the first half of 2026, reporting a net profit of 7.316 million yuan, turning around from a loss of 58.5709 million yuan in the same period last year.37d ago